Skip to main content

Table 6 Risk for cardiovascular disease according to exposure to TNFis in the IPTW-adjusted population

From: Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis

 

HR (95% CI)

P-value

TNFi not exposed

1.00 (reference)

 

TNFi exposed

0.60 (0.23–1.54)

0.287

  1. TNFi tumor necrosis factor inhibitor, IPTW inverse probability of treatment weighting, HR hazard ratio, CI confidence interval